Gerrit Herman Veeneman

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Oss, NL (2008 - 2011)
Schaijk, NL (2004 - 2017)

Company Filing History:

Merck Sharp + Dohme B.v.

patents

Years Active: 2004-2017

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9540361 - N-substituted azetidine derivatives (2017-01-10),

2. 8063102 - Tetrahydronaphthalen-2-ol derivatives (2011-11-22),

3. 7846966 - Chroman derivatives as estrogenic compounds (2010-12-07),

4. 7696190 - 16Alpha-methyl or ethyl substituted estrogens (2010-04-13),

5. 7531571 - Chroman derivatives as estrogenic compounds (2009-05-12),

6. 7335659 - [object Object] (2008-02-26),

7. 7214706 - Chroman derivatives as estrogenic compounds (2007-05-08),

8. 6756375 - 10-Aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use (2004-06-29),

9. 6686371 - Non-steroidal, tetracylic compounds for estrogen-related treatments (2004-02-03),

10. 6677329 - Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 (2004-01-13),

Title: Gerrit Herman Veeneman: Innovator in Pharmaceutical Chemistry

Introduction

Gerrit Herman Veeneman is a notable inventor based in Schaijk, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on developing novel compounds for therapeutic applications.

Latest Patents

Among his latest patents, Veeneman has developed N-substituted azetidine derivatives. This invention relates to novel compounds that have potential applications in treating various conditions, including ovulatory dysfunction, several types of cancer, and osteoporosis. These derivatives exhibit estrogen receptor alpha antagonistic activity, particularly in hormone treatment-resistant breast cancer. Another significant patent involves tetrahydronaphthalen-2-ol derivatives, which are aimed at addressing lower urinary tract symptoms, benign prostate hyperplasia, and various cancers, among other health issues.

Career Highlights

Throughout his career, Veeneman has worked with prominent companies such as N.V. Organon and Akzo Nobel N.V. His experience in these organizations has allowed him to contribute to the advancement of pharmaceutical innovations.

Collaborations

Veeneman has collaborated with notable colleagues, including Hubert Jan Jozef Loozen and Neeltje Miranda Teerhuis. These partnerships have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Gerrit Herman Veeneman's contributions to pharmaceutical chemistry through his innovative patents have the potential to impact various medical fields significantly. His work continues to pave the way for advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.